Frequency of Dermatological Side Effects of Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Type 1 Diabetes

Binder, Elisabeth B.; Lange, O.; Edlinger, Michael; Meraner, Dagmar; D, Abt; Möser, Christine V.; Steichen, Elisabeth; Hofer, Susanne

doi:10.1055/s-0034-1394381

Cited by 47 publications

(63 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Skin reactions and infections have been reported at the sensor site with first-generation CGM systems [29–31] and when using insulin pump infusion sets [32, 33]. Despite improvements to technology, skin reactions and infections continue to be an ongoing concern for individuals with T1D who use these devices [33–35].…”

Section: Biopsychosocial Factors Associated With Cgm and Insulin Pumpmentioning

confidence: 99%

“…Despite improvements to technology, skin reactions and infections continue to be an ongoing concern for individuals with T1D who use these devices [33–35]. They are particularly common in children and adolescents [29, 32], when sweating and activity causes frequent skin irritation and adhesive problems [31].…”

Section: Biopsychosocial Factors Associated With Cgm and Insulin Pumpmentioning

confidence: 99%

See 1 more Smart Citation

Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field

et al. 2018

View full text Add to dashboard Cite

Purpose of Review Summarize biopsychosocial factors associated with using continuous glucose monitors (CGMs), insulin pumps, and artificial pancreas (AP) systems and provide a “call to the field” about their importance to technology uptake and maintained use. Recent Findings Insulin pumps and CGMs are becoming standard of care for individuals with type 1 diabetes (T1D). AP systems combining a CGM, insulin pump, and automated dosing algorithm are available for commercial use. Despite improved glycemic control with AP system use, numerous barriers exist which may limit their benefit. Studies on components of AP systems (pumps, CGMs) are limited and demonstrate mixed results of their impact on fear of hypoglycemia, adherence, quality of life, depression and anxiety, and diabetes distress. Studies examining biopsychological factors associated specifically with sustained use of AP systems are also sparse. Summary Biological, psychological and social impacts of AP systems have been understudied and the information they provide has not been capitalized upon.

show abstract

Section: Biopsychosocial Factors Associated With Cgm and Insulin Pumpmentioning

confidence: 99%

Section: Biopsychosocial Factors Associated With Cgm and Insulin Pumpmentioning

confidence: 99%

Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Both CSII and CGM systems adhere to the surface of the skin with a catheter or a wire, respectively, inserted into the upper dermis. The patches that stick to the skin adhere for between 3 and 14 days depending on the manufacturer and, in some cases, these can cause skin problems . However, the factors associated with dermatological complications, including age, glycemic control, and sex have received little attention, and few studies have described skin problems in CGM users .…”

Section: Introductionmentioning

confidence: 99%

High frequencies of dermatological complications in children using insulin pumps or sensors

et al. 2018

View full text Add to dashboard Cite

show abstract

“…[157] Repeated injections into the same SC tissue and the increasing use of insulin pump therapy (IPT) carries risks of abscess formation and scarring. [158159160]…”

Section: Adverse Events Of Faulty Techniquementioning

confidence: 99%

Forum for injection technique and therapy expert recommendations, India: The Indian recommendations for best practice in insulin injection technique, 2017

Tandon

Kalra

Balhara

et al. 2017

Indian J Endocr Metab

View full text Add to dashboard Cite

Health-care professionals in India frequently manage injection or infusion therapies in persons with diabetes (PWD). Patients taking insulin should know the importance of proper needle size, correct injection process, complication avoidance, and all other aspects of injection technique from the first visit onward. To assist health-care practitioners in their clinical practice, Forum for Injection Technique and Therapy Expert Recommendations, India, has updated the practical advice and made it more comprehensive evidence-based best practice information. Adherence to these updated recommendations, learning, and translating them into clinical practice should lead to effective therapies, improved outcomes, and lower costs for PWD.

show abstract

Frequency of Dermatological Side Effects of Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Type 1 Diabetes

Abstract: Skin-related complications during CSII are frequent and regular examination of the insertion sites is crucial. To verify the occurrence of lipoatrophy associated with insulin pump therapy - an otherwise rare complication - larger studies would be needed.

Cited by 47 publications

References 26 publications

Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field

Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field

High frequencies of dermatological complications in children using insulin pumps or sensors

Forum for injection technique and therapy expert recommendations, India: The Indian recommendations for best practice in insulin injection technique, 2017

Contact Info

Product

Resources

About